Parliamentary questions

2258. Deputy Mattie McGrath asked the Minister for Health the specific safeguards in place to prevent drugs used for abortions (mifepristone and misoprostol) being supplied to or obtained by unauthorised people or used for abortions outside the terms of the Health (Regulation of Termination of Pregnancy) Act 2018; whether any regulatory changes have been made in light of evidence of coercive abort…

2259. Deputy Mattie McGrath asked the Minister for Health if she is aware of any incidences where women requested abortion pill reversal treatments after coerced or forced abortion; if the possibility of prescribing progesterone in this circumstance has been examined; and if she will make a statement on the matter. [43459/26]

2260. Deputy Michael Cahill asked the Minister for Health the reason a cancer patient (details supplied) has not been granted a discretionary medical card and has been repeatedly asked for the same information; and if she will make a statement on the matter. [43482/26]

2261. Deputy Shónagh Ní Raghallaigh asked the Minister for Health the current average waiting time for children and adolescents in County Kildare to access CAMHS; the measures being taken to reduce waiting lists; and if she will make a statement on the matter. [43484/26]

2262. Deputy Shónagh Ní Raghallaigh asked the Minister for Health whether she is satisfied that GP and primary care services in south Kildare have sufficient capacity to meet the needs of a growing population; whether any additional primary care centres are planned for the region; and if she will make a statement on the matter. [43485/26]

2263. Deputy Shónagh Ní Raghallaigh asked the Minister for Health the number of people in County Kildare currently awaiting orthodontic treatment through the public system; the average waiting time for treatment; and if she will make a statement on the matter. [43492/26]

2264. Deputy Ged Nash asked the Minister for Health if her Department and the HSE will investigate and address the case of a person (details supplied); and if she will make a statement on the matter. [43494/26]

2265. Deputy Mairéad Farrell asked the Minister for Health the position in relation to the reimbursement of internationalised normalised ratio test strips and machines for persons who require long-term oral anticoagulant therapy with warfarin; and if she will make a statement on the matter. [43499/26]

2266. Deputy Pádraig O'Sullivan asked the Minister for Health the number of patients receiving standard oral nutritional supplements reimbursed under the community drug schemes, broken down by those receiving first-line products on List A and those receiving non first-line products on List B, in tabular form; and if she will make a statement on the matter. [43512/26]

2267. Deputy Pádraig O'Sullivan asked the Minister for Health if she is satisfied that the categorisation of standard oral nutritional supplements into List A first-line products and List B non first-line products under the Standard Oral Nutritional Supplements First-line Prescribing List for Adults Living in the Community 2019 remains clinically appropriate; whether that list has been reviewed si…

2268. Deputy Pádraig O'Sullivan asked the Minister for Health the total expenditure by the Health Service Executive on standard oral nutritional supplements reimbursed under the community drug schemes in each year since 2021, in tabular form; and if she will make a statement on the matter. [43514/26]

2269. Deputy Pádraig O'Sullivan asked the Minister for Health the process by which standard oral nutritional supplements are assessed and assigned to List A or List B for reimbursement under the community drug schemes; the criteria applied; the body responsible for making these determinations; and if she will make a statement on the matter. [43515/26]

2270. Deputy Pádraig O'Sullivan asked the Minister for Health the number of prior reimbursement approval applications for List B standard oral nutritional supplements received by the Primary Care Reimbursement Service in each year since 2021; the number approved and refused respectively; the average processing time for such applications; and if she will make a statement on the matter. [43516/26]

2271. Deputy Pádraig O'Sullivan asked the Minister for Health whether she will review the requirement for six-monthly renewal of reimbursement approval for List B standard oral nutritional supplements, given the administrative burden this places on general practitioners, dietitians and hospital clinicians; and if she will make a statement on the matter. [43517/26]

2272. Deputy Robert O'Donoghue asked the Minister for Health the number of people referred to an urgent symptomatic breast disease clinic attended within ten days, between 11-20 days, 21 days or longer by hospital for each of the years 2019, 2020, 2021, 2022, 2023, 2024, 2025 and to date in 2026, in tabular form; and if she will make a statement on the matter. [43519/26]

2273. Deputy Robert O'Donoghue asked the Minister for Health the number of people referred to a lung rapid access clinic attended within ten days, between 11-20 days, 21 days or longer by hospital for each of the years 2019, 2020, 2021, 2022, 2023, 2024, 2025 and to date in 2026, in tabular form; and if she will make a statement on the matter. [43520/26]

2274. Deputy Robert O'Donoghue asked the Minister for Health the number of people referred to a prostate rapid access clinic attended within 20 days, between 21-25 days, 25 days or longer by hospital for each of the years 2019, 2020, 2021, 2022, 2023, 2024, 2025 and to date in 2026, in tabular form; and if she will make a statement on the matter. [43521/26]

2275. Deputy Louis O'Hara asked the Minister for Health further to Parliamentary Question No. 1227 of 28 April 2026, if the HSE will issue a response; and if she will make a statement on the matter. [43537/26]

2276. Deputy Barry Ward asked the Minister for Health the position regarding any legislative requirement for retailers of smokeless nicotine and tobacco products to be either registered or licenced to sell these products; and if she will make a statement on the matter. [43539/26]

2277. Deputy Barry Ward asked the Minister for Health the total funding allocated to, and expenditure incurred by, the HSE QUIT smoking cessation services in each of the years 2023, 2024, 2025 and to date in 2026; the services and supports funded under this allocation; the expenditure attributable to each service or programme, in tabular form; and if she will make a statement on the matter. [43542…

2278. Deputy Ruairí Ó Murchú asked the Minister for Health if the treating member State determines that a telemedicine consult is sufficient under the EU Cross Border Health Directive, therefore no face-to-face consultation is necessary prior to in-patient care; the way in which an Irish patient or the HSE dictate to the treating member State how to provide the healthcare; and if she will make a s…

2279. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the recruitment source from which successful consultant appointees were recruited; and if so, to provide the number and percentage of consultant appointments arising from each recruitment channel in 2023, 2024, 2025 and to date in 2026. [43566/26]

2280. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred on consultant recruitment advertising in each year from 2021 to 2025, broken down by publication, website, platform and recruitment channel. [43567/26]

2281. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money review has been undertaken regarding consultant recruitment advertising expenditure; and if so, to provide copies or summaries of such reviews. [43568/26]

2282. Deputy Ken O'Flynn asked the Minister for Health the number of consultant applicants, interviewees and appointees arising from advertisements placed in the British Medical Journal in each year from 2023 to 2026. [43569/26]